HIV treatment
The latest news about HIV treatment: headlines, AI summaries and the full story from every source.
- Gilead Sciences Reports Strong Q3 2026 Results Driven by HIV and Oncology Growth
- Gilead Sciences Receives Multiple FDA Approvals and Label Expansions
- GSK-owned ViiV Healthcare's Cabenuva Succeeds in Late-Stage HIV Trial
- U.S. FDA Approves Gilead's Once-Daily HIV Pill Bixlenvo
- Merck and Gilead Report Positive Phase 3 Trial Results for Combination HIV Pill
- GSK Reports Strong Q1 Earnings with Sales Growth and Guidance Reiteration